Page last updated: 2024-08-21

plumbagin and Hormone-Dependent Neoplasms

plumbagin has been researched along with Hormone-Dependent Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Annab, LA; Banerji, A; Gopinath, G; Srinivas, G; Srinivas, P	1

Other Studies

1 other study(ies) available for plumbagin and Hormone-Dependent Neoplasms

Article	Year
Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG-1 ovarian cancer cells. Molecular carcinogenesis, 2004, Volume: 39, Issue:1 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; BRCA1 Protein; Cell Division; Emodin; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; In Situ Nick-End Labeling; Membrane Potentials; Mitochondria; Naphthoquinones; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; RNA, Antisense; RNA, Messenger; Tamoxifen; Tumor Cells, Cultured	2004

Article

Year

Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG-1 ovarian cancer cells.

Molecular carcinogenesis, 2004, Volume: 39, Issue:1

Topics: Antineoplastic Agents, Phytogenic; Apoptosis; BRCA1 Protein; Cell Division; Emodin; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; In Situ Nick-End Labeling; Membrane Potentials; Mitochondria; Naphthoquinones; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; RNA, Antisense; RNA, Messenger; Tamoxifen; Tumor Cells, Cultured

2004